Rare inflammatory disease responds best to the one-two punch of JAK inhibition | Newswise: News for Journalists

X

Corresponding author Kim Nichols, MD, St. Jude Division of Cancer Predisposition director, a part of the Department of Oncology.

Credit: St. Jude Children's Research Hospital

Corresponding author Kim Nichols, MD, St. Jude Division of Cancer Predisposition director, a part of the Department of Oncology.

« Rare inflammatory disease responds best to the one-two punch of JAK inhibition

0.11253